Although evaluation of possible occupational asthma may be complex, it can
be pursued systematically by first assessing whether asthma is present, and
then determining whether asthma is caused or triggered by the workplace or
by alternative or confounding nonoccupational explanations. A detailed his
tory is of great importance in raising suspicion of occupational asthma, bu
t studies have shown that even detailed histories obtained by experienced s
pecialists can lead to inaccurate conclusions about the presence or absence
of occupational asthma. Consequently, objective measurements should be per
formed to establish the diagnosis of occupational asthma whenever possible.
If the patient is still working in the workplace, work-related changes in
spirometry or peak flow measurements can confirm the diagnosis. For occupat
ional asthma from some airborne sensitizers, immediate-type skin testing or
in vitro tests for specific IgE may establish sensitization. However, ther
e is evidence that for some isocyanates, in vitro tests for specific IgG se
rum antibody levels correlate better with documented bronchospasm from isoc
yanate exposure, even though the IgG antibody is not thought to be pathogen
ic. Controlled, specific inhalation tests may be valuable, but they should
be performed only, under experienced medical supervision. Intervention shou
ld be focused on reducing or avoiding harmful workplace exposures so that p
ermanent lung impairment and need for chronic medical treatment are avoided
. Assessment of permanent impairment/disability from occupational asthma op
timally, should be determined 2 years after the removal from occupational e
xposure, when improvement has been shown to plateau and the patient will li
kely have reached maximal medical improvement.